FDA unauthorizes use of Regeneron, Eli Lilly antibody treatments; new version of omicron reported: Live COVID-19 updates

The FDA said the two treatments are unlikely to work against the omicron variant, which makes up 99% of U.S. cases. Latest COVID-19 news.

     

from USATODAY - News Top Stories https://ift.tt/3ACBDiP
via IFTTT